Clinical Trials Browser

Phase 2/3 × Leukemia, Myeloid, Acute × Homoharringtonine × Clear all

NCT05805098 2023-04-07

VHA

Phase 2/3 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute